1
|
Tsao CM, Yan MD, Shih YL, et al: SOX1
functions as a tumor suppressor by antagonizing the WNT/β-catenin
signaling pathway in hepatocellular carcinoma. Hepatology.
56:2277–2287. 2012.PubMed/NCBI
|
2
|
Jiang H, Xia J, Kang J, Ding Y and Wu W:
Short hairpin RNA targeting beta-catenin suppresses cell
proliferation and induces apoptosis in human gastric carcinoma
cells. Scand J Gastroenterol. 44:1452–1462. 2009. View Article : Google Scholar : PubMed/NCBI
|
3
|
Yoo NJ, Kim S and Lee SH: Mutational
analysis of WTX gene in Wnt/ beta-catenin pathway in gastric,
colorectal, and hepatocellular carcinomas. Dig Dis Sci.
54:1011–1014. 2009. View Article : Google Scholar : PubMed/NCBI
|
4
|
Mukherjee N, Bhattacharya N, Alam N, Roy
A, Roychoudhury S and Panda CK: Subtype-specific alterations of the
Wnt signaling pathway in breast cancer: clinical and prognostic
significance. Cancer Sci. 103:210–220. 2012. View Article : Google Scholar
|
5
|
Kang YJ, Park HJ, Chung HJ, et al:
Wnt/β-catenin signaling mediates the antitumor activity of magnolol
in colorectal cancer cells. Mol Pharmacol. 82:168–177. 2012.
|
6
|
Scholer-Dahirel A, Schlabach MR, Loo A, et
al: Maintenance of adenomatous polyposis coli (APC)-mutant
colorectal cancer is dependent on Wnt/beta-catenin signaling. Proc
Natl Acad Sci USA. 108:17135–17140. 2011. View Article : Google Scholar
|
7
|
Bjorklund CC, Ma W, Wang ZQ, et al:
Evidence of a role for activation of Wnt/beta-catenin signaling in
the resistance of plasma cells to lenalidomide. J Biol Chem.
286:11009–11020. 2011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Gehrke I, Gandhirajan RK and Kreuzer KA:
Targeting the WNT/beta-catenin/TCF/LEF1 axis in solid and
haematological cancers: Multiplicity of therapeutic options. Eur J
Cancer. 45:2759–2767. 2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Wang X, Meng X, Sun X, et al:
Wnt/β-catenin signaling pathway may regulate cell cycle and
expression of cyclin A and cyclin E protein in hepatocellular
carcinoma cells. Cell Cycle. 8:1567–1570. 2009.
|
10
|
Tannock IF: The relation between cell
proliferation and the vascular system in a transplanted mouse
mammary tumour. Br J Cancer. 22:258–273. 1968. View Article : Google Scholar : PubMed/NCBI
|
11
|
Li C, Liu B, Dai Z and Tao Y: Knockdown of
VEGF receptor-1 (VEGFR-1) impairs macrophage infiltration,
angiogenesis and growth of clear cell renal cell carcinoma (CRCC).
Cancer Biol Ther. 12:872–880. 2011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Man K, Ng KT, Xu A, et al: Suppression of
liver tumor growth and metastasis by adiponectin in nude mice
through inhibition of tumor angiogenesis and downregulation of Rho
kinase/IFN-inducible protein 10/matrix metalloproteinase 9
signaling. Clin Cancer Res. 16:967–977. 2010. View Article : Google Scholar
|
13
|
Hu J, Chen C, Su Y, DU J, Qian X and Jin
Y: Vascular endothelial growth factor promotes the expression of
cyclooxygenase 2 and matrix metalloproteinases in Lewis lung
carcinoma cells. Exp Ther Med. 4:1045–1050. 2012.PubMed/NCBI
|
14
|
Cole M and Bromberg M: Tissue factor as a
novel target for treatment of breast cancer. Oncologist. 18:14–18.
2013. View Article : Google Scholar : PubMed/NCBI
|
15
|
Hamed EA, Zakhary MM and Maximous DW:
Apoptosis, angiogenesis, inflammation, and oxidative stress: basic
interactions in patients with early and metastatic breast cancer. J
Cancer Res Clin Oncol. 138:999–1009. 2012. View Article : Google Scholar
|
16
|
Cattaruzza S, Ozerdem U, Denzel M, et al:
Multivalent proteoglycan modulation of FGF mitogenic responses in
perivascular cells. Angiogenesis. 16:309–327. 2013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Calviello G, Resci F, Serini S, et al:
Docosahexaenoic acid induces proteasome- dependent degradation of
beta-catenin, down-regulation of survivin and apoptosis in human
colorectal cancer cells not expressing COX-2. Carcinogenesis.
28:1202–1209. 2007. View Article : Google Scholar : PubMed/NCBI
|
18
|
Stockmann C, Kerdiles Y, Nomaksteinsky M,
et al: Loss of myeloid cell-derived vascular endothelial growth
factor accelerates fibrosis. Proc Natl Acad Sci USA. 107:4329–4334.
2010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Blavier L, Lazaryev A, Shi XH, Dorey FJ,
Shackleford GM and DeClerck YA: Stromelysin-1 (MMP-3) is a target
and a regulator of Wnt1-induced epithelial-mesenchymal transition
(EMT). Cancer Biol Ther. 10:198–208. 2010. View Article : Google Scholar : PubMed/NCBI
|
20
|
Wu B, Crampton SP and Hughes CC: Wnt
signaling induces MMP expression and regulates T cell
transmigration. Immunity. 26:227–239. 2007. View Article : Google Scholar : PubMed/NCBI
|
21
|
Fire A, Xu S, Montgomery MK, Kostas SA,
Driver SE and Mello CC: Potent and specific genetic interference by
double-stranded RNA in Caenorhabditis elegans. Nature. 391:806–811.
1998. View Article : Google Scholar : PubMed/NCBI
|
22
|
Hannon GJ: RNA interference. Nature.
418:244–251. 2002. View
Article : Google Scholar : PubMed/NCBI
|
23
|
Guo S, Colbert LS, Fuller M, Zhang Y and
Gonzalez-Perez RR: Vascular endothelial growth factor receptor-2 in
breast cancer. Biochim Biophys Acta. 1806:108–121. 2010.PubMed/NCBI
|
24
|
Qiu Z, Huang C, Sun J, et al: RNA
interference-mediated signal transducers and activators of
transcription 3 gene silencing inhibits invasion and metastasis of
human pancreatic cancer cells. Cancer Sci. 98:1099–2006. 2007.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Tsareva SA, Moriggl R, Corvinus FM,
Wiederanders B, Schütz A, Kovacic B and Friedrich K: Signal
transducer and activator of transcription 3 activation promotes
invasive growth of colon carcinomas through matrix
metalloproteinase induction. Neoplasia. 9:279–291. 2007. View Article : Google Scholar
|
26
|
Chen J, Wang J, Lin L, et al: Inhibition
of STAT3 signaling pathway by nitidine chloride suppressed the
angiogenesis and growth of human gastric cancer. Mol Cancer Ther.
11:277–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
27
|
Wang XH, Liu BR, Qu B, et al: Silencing
STAT3 may inhibit cell growth through regulating signaling pathway,
telomerase, cell cycle, apoptosis and angiogenesis in
hepatocellular carcinoma: potential uses for gene therapy.
Neoplasma. 58:158–171. 2011. View Article : Google Scholar
|
28
|
Ding Y, Boguslawski EA, Berghuis BD, et
al: Mitogen-activated protein kinase kinase signaling promotes
growth and vascularization of fibrosarcoma. Mol Cancer Ther.
7:648–658. 2008. View Article : Google Scholar : PubMed/NCBI
|
29
|
Zhang YH, Wei W, Xu H, Wang YY and Wu WX:
Inducing effects of hepatocyte growth factor on the expression of
vascular endothelial growth factor in human colorectal carcinoma
cells through MEK and PI3K signaling pathways. Chin Med J (Engl).
120:743–748. 2007.
|
30
|
Wang M, Zhang W, Crisostomo P, Markel T,
Meldrum KK, Fu XY and Meldrum DR: STAT3 mediates bone marrow
mesenchymal stem cell VEGF production. J Mol Cell Cardiol.
42:1009–1015. 2007. View Article : Google Scholar : PubMed/NCBI
|
31
|
Yu P, Passam FH, Yu DM, Denyer G and
Krilis SA: Beta2-Glycoprotein I inhibits vascular endothelial
growth factor and basic fibroblast growth factor induced
angiogenesis through its amino terminal domain. J Thromb Haemost.
6:1215–1223. 2008. View Article : Google Scholar
|
32
|
Hara T, Miyazaki H, Lee A, Tran CP and
Reiter RE: Androgen receptor and invasion in prostate cancer.
Cancer Res. 68:1128–1135. 2008. View Article : Google Scholar : PubMed/NCBI
|
33
|
Chen JS, Huang XH, Wang Q, et al: Sonic
hedgehog signaling pathway induces cell migration and invasion
through focal adhesion kinase/AKT signaling-mediated activation of
matrix metalloproteinase (MMP)-2 and MMP-9 in liver cancer.
Carcinogenesis. 34:10–19. 2013. View Article : Google Scholar
|
34
|
Segarra M, Ohnuki H, Maric D, et al:
Semaphorin 6A regulates angiogenesis by modulating VEGF signaling.
Blood. 120:4104–4115. 2012. View Article : Google Scholar : PubMed/NCBI
|